Clinical Trial Update: A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes [Phase 2]

View source ↗

Summary

This update covers a Phase 2b study of GCS-100 in patients with diabetic kidney disease, noting that the study status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• GCS-100

Snippet

Sponsor: La Jolla Pharmaceutical Company | Conditions: Diabetic Chronic Kidney Disease | Phase 2 | Status: UNKNOWN